Literature DB >> 3021492

Effect of nedocromil sodium on TXB2, LTB4 and LTD4 synthesis by alveolar macrophages from asthmatic patients.

M Damon, C Chavis, A Crastes de Paulet, F B Michel, P Godard.   

Abstract

Arachidonic acid metabolites may play a role in the pathophysiology of bronchial asthma, influencing bronchial tone, airways inflammation and bronchial hyperreactivity. This study was designed to investigate the effect of nedocromil sodium, at a range of concentrations, on the metabolism of arachidonic acid released from alveolar macrophages (AMs) obtained by bronchoalveolar lavage in healthy and asthmatic subjects. The only effect of nedocromil sodium observed in this study was a slight decrease in LTD4 synthesis by AMs from asthmatic patients. This possible effect of nedocromil sodium on LTD4 metabolism deserves further investigation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3021492

Source DB:  PubMed          Journal:  Eur J Respir Dis Suppl        ISSN: 0106-4347


  5 in total

Review 1.  Long-term drug treatment of asthma in children.

Authors:  K F Kerrebijn
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Respiratory and allergic disease. I.

Authors:  K F Chung; P J Barnes
Journal:  Br Med J (Clin Res Ed)       Date:  1988-01-02

3.  Effect of inhibitors on histamine release from mast cells recovered by bronchoalveolar lavage in basenji-greyhound and mongrel dogs.

Authors:  C P Sommerhoff; M L Osborne; S C Lazarus
Journal:  Agents Actions       Date:  1990-11

4.  Nedocromil sodium inhibits the A23187- and opsonized zymosan-induced leukotriene formation by human eosinophils but not by human neutrophils.

Authors:  P L Bruijnzeel; M L Hamelink; P T Kok; J Kreukniet
Journal:  Br J Pharmacol       Date:  1989-03       Impact factor: 8.739

5.  Strain-dependency of leukotriene C4 generation from isolated lungs of immunized mice.

Authors:  C Zuany-Amorim; B B Vargaftig; J Maclouf; M Pretolani
Journal:  Br J Pharmacol       Date:  1994-08       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.